Cite
HARVARD Citation
Zasowski, E. et al. (n.d.). Clinical and Economic Comparison of Ceftaroline Fosamil (CPT) and Daptomycin (DAP) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI). Open forum infectious diseases. p. S548. [Online].